Home » Patent Law Updates » New Settlements and Verdicts

Patent Law Summaries

Page 3 of 3 of Patent Law Summaries » New Settlements and Verdicts« First  <  1 2 3

Celerity, Inc. v. Ultra Clean Technology Systems & Service, Inc.

No. 3:05-cv-03560-MMC 2007 WL 2983099,
N.D.Cal., 06/25/2007

Holding: In this case involving patents relating to modular gas delivery technologies, the jury rendered a plaintiff’s verdict, awarding plaintiff Celerity, Inc. the sum of $13,900. According to Celerity, this amount was supposed to represent an 8 percent royalty rate on all sales of defendant Ultra Clean's Predator IGS (an integrated gas-delivery system) that had been made at the time of trial. The jury found that defendant infringed one of patents in dispute. The jury did not issue a finding of invalidity of any of the patent claims, contrary to Ultra Clean’s position that patents in issue should be declared as invalid. More...

O’Keefe v. ALLCO Millwork and Jeremy Glass

3:05-cv-02715, 2007 WL 901634 ,
N.D.Cal., 02/05/2007

Holding: In this case for infringement of patent directed toward techniques for the manufacture of fire-resistant glazing glass products, plaintiff patentee and defendants entered into a settlement agreement that would pay plaintiff the sum of $1,000,000.00 in damages and that would make defendants refrain from further manufacturing and distributing glass products. More...

Informatica Corporation v. Business Objects Data Integration, Inc.

C 02-03378, 2007 WL 1765179,
N.D.Cal., 05/17/2007

Holding: In this patent infringement suit over patents covering a method of transforming data in extract, transform, and load (“ETL”) process of building data warehouse through the use of “transformation objects,” a jury verdict was rendered in favor of plaintiff patent holder, and based on the findings that defendant indirectly infringed plaintiff’s patents, and that such infringement was willful, granted an award of $25,240,000.00 as reasonable royalty damages. More...

Lucent Technologies Inc., et al.  v. Gateway Inc., et al.

02-CV-2060; 03-CV-0699; 03-CV-1108, 2007 WL 1039302,
S.D.Cal., 02/22/2007

Holding: In this infringement suit involving patents that were directed toward music coding that goes through a process so that musical compositions can be heard, or downloaded, from the computer, jury verdict was rendered in favor of patent holder (Lucent Technologies) against intervenor Microsoft, where the amount awarded reached $769,028,351.00 for each patent, computed from a 50 per cent royalty fee for each of the two patents, for a total award of $1,538,056,702.00. More...

Genentech Incorporated, et al. v. Insmed Incorporated, et al.

c 04 5429 cw, 2007 WL 686050 ,
N.D.Cal., 02/08/2007

Holding: In this infringement suit involving patents directed toward proteins used in growth hormone drugs for children with growth disorders, jury verdict was rendered in favor of plaintiffs which were awarded the sum of $7,500,000.00 in damages, and 15% to 20% of the revenues earned by defendants from the distribution of the latter’s competing drug.

More...

Page 3 of 3 of Patent Law Summaries » New Settlements and Verdicts« First  <  1 2 3

Patent Law Commentaries

Following are Patent Law Commentaries elaborating on the significance of the most important of the Patent Law Summaries.

Page 1 of 2 of Patent Law Commentaries  1 2 >

Cohesive Technologies v. Waters: Anticipated Though Non-Obvious?

Posted: 12/11/2008

Commentary: In Cohesive Technologies, Inc. v. Waters Corporation, 543 F.3d 1351 (Fed. Cir. 2008), the U.S. Court of Appeals for the Federal Circuit held that an invention may be anticipated, even though it is proven non-obvious. The Court drew a clear separating line between the novelty analysis of 35 U.S.C. section 102 and the non-obviousness analysis of 35 U.S.C. section 103(a). While the general holding is perhaps well-founded, in a case such as this where the references cited under §102 and §103 were identical, the decision to remand seems wasteful and inappropriate. More...

Related summary: Federal Circuit Remands Waters' Drug Testing Patent Dispute with Cohesive Technologies

Quanta Computer v. LG Electronics: Reviving Exhaustion, Applying It to Method Patents

Quanta Computer v. LG Electronics
Posted: 08/15/2008

Commentary: In the case Quanta Computer v. LG Electronics, ___ U.S. ____, 128 S.Ct. 2109 (2008), the United States Supreme Court clarifies and expands upon its holding in United States v. Univis Lens Co. In Univis, the court held that a patent is exhausted upon the sale of unfinished components that substantially embody the patent and which have no use except to practice the patent. In Quanta, the court clarified that the same analysis applies to process or method patents, not just product patents: When a component substantially embodies the process and cannot be used for any purpose other than to practice the patent, the process patent is exhausted upon sale of that component. The decision makes it more difficult for patentees to extract royalties from multiple parties for the same device. However, it revitalizes the integrity of the exhaustion doctrine and provides more certainty for downstream purchasers. More...

Related summary: Supreme Court Reverses Federal Circuit’s Ruling, Finds in Favor of Quanta in LG’s Computer Technology Patent Suit

Acumed II Addresses the Issue of Claim Preclusion and When a Patent Claim Could Have Been Brought

Acumed, LLC v. Stryker Corp., et al.
Posted: 05/20/2008

Commentary: In the recent case of Acumed, LLC v. Stryker Corp.,et al., (No. 2007-1115) (Fed. Cir., May 13, 2008) (“Acumed II”), the Federal Circuit addressed the meaning and application of language barring re-litigation of claims that “could have been brought” in a prior patent infringement case. More...

Related summary: Federal Circuit Reverses District Court’s Ruling in Acumed v. Stryker, Remands Case

Agrizap and Ortho-McNeil: Two Sides of Post-KSR Obviousness

Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories, Inc., et al.
Posted: 05/16/2008

Commentary: In KSR v. Teleflex, 550 U.S. ____, 127 S. Ct. 1727 (2007), the U.S. Supreme Court broadened the applicable test in determining whether an invention is “obvious.” As predicted by patent law pundits, the KSR decision was followed by a number of cases in which infringers defended their actions – and won – by having the patent in question declared invalid for obviousness under this new standard. The Court of Appeals for the Federal Circuit (the CAFC) recently heard and decided two separate cases that addressed the issue of obviousness post-KSR. These cases shed further light on the new standard for determining obviousness. While the results are quite different, the lessons for practitioners are, ultimately, the same. More...

Related summary: Federal Circuit Affirms Validity of Ortho-McNeil’s Patent On Epilepsy Drug Topomax

Judkins v. HT Window Fashion: Can’t Stop a Patent Holder from Contacting Your Clients About Possible Infringement

Judkins v. HT Window Fashion Corp.
Posted: 05/13/2008

Commentary: When a patent-holder discovers infringement, it’s not unreasonable for him to want to notify the alleged infringer’s clients of the infringement. Of course the alleged infringer would prefer that this communication with its clients not take place. But, as the Judkins case instructs, it will be nearly impossible for an alleged infringer to stop a patent holder from contacting its clients. More...

Related summary: Patent Owners Allowed to Warn Buyers about Competitor's Infringing Products: Judkins v. HT Window Fashion Corp.

Page 1 of 2 of Patent Law Commentaries  1 2 >

Sponsored Ads


Discussion Forums

Patent Law

Enter our NEW discussion forums to interact with other readers about Patent Law.

Companies Mentioned

Patent Law

The following companies are mentioned in Patent Law Updates:

Samsung Electronics America, Inc.

Stryker Corp.

Boston Scientific Corp.

Smithkline Beecham Corp. (d.b.a. GlaxoSmithKline, plc.)

United States Patent and Trademark Office

HT Window Fashion Corp.

Mylan Laboratories, Inc.

Mylan Pharmaceutical, Inc.

Ortho-McNeil Pharmaceutical, Inc.

Acumed, LLC

Audiovox Communications Corp.

Stryker Sales Corp.

McKesson Information Solutions, Inc.

Stryker Orthopaedics

Howmedica Osteonics Corp.

Bridge Medical, Inc.

Smith & Nephew, Inc.

Cohesive Technologies, Inc.

Waters Corp.

LG Electronics, Inc.

Quanta Computer, Inc.

Motorola, Inc.

Nokia, Inc.

Sanyo North America Corp.

Scimed Life Systems Inc.

Medtronic USA, Inc.

NEC Corporation of America

Samsung Telecommunications America LLC.

Apotex, Inc.

Cooper Technologies Company

Medtronic, Inc.

Sony Ericcson Mobile Communications (USA), Inc.

Nokia Corp.

Apotex Corp.

Thomas & Betts Corp.

Medtronic Vascular Galway, Ltd.

Sony Ericcson Mobile Communications AG

Nokia Inc.

Roche Palo Alto LLC

800 Adept, Inc.

Bancorp Services, LLC

Panasonic Corporation of North America

Impax Laboratories, Inc.

Allergan, Inc.

Targus Information Corp.

Benefit Finance Partners, LLC

Curitel Communications, Inc.

Aventis Pharmaceuticals Inc.

Thomson Corp. d.b.a. Thomson Financial LLC and Thomson Financial Municipals Group

Murex Securities, Ltd.

Additional Resources

Patent Law

Manual for Patent Examining Procedure (pdf, 56mb)

Patent Act (pdf, 1.4mb)

Patent Rules (pdf, 3.4mb)

Need a Lawyer?

The lawyers at Zuber & Taillieu LLP have top credentials, and offer exceptional services in all areas of law found on LawUpdates.com.

Visit Zuber & Taillieu LLP